Country-level correlates of cervical cancer mortality in Latin America and the Caribbean

Salud Publica de Mexico

Volumn 55, Issue 1, 2013, Pages 5-15

  Pereira Scalabrino, Ana ^a   Almonte, Maribel ^b   dos Santos Silva, Isabel ^c  

^a UNIVERSITY OF CHILE   (Chile)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Latin america; Mass screening; Papillomaviridae; Uterine cervical neoplasms

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CENTRAL AMERICA; CHILD; EARLY DIAGNOSIS; FEMALE; HUMAN; INFANT; MIDDLE AGED; MORTALITY; PAPILLOMAVIRUS INFECTION; PRESCHOOL CHILD; PREVALENCE; SOUTH AND CENTRAL AMERICA; STATISTICS; UTERINE CERVIX TUMOR; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CARIBBEAN REGION; CHILD; CHILD, PRESCHOOL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INFANT; LATIN AMERICA; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84875087956     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: 10.1590/S0036-36342013000100004     Document Type: Article

References (54)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin D. GLOBOCAN 2008: Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. International Agency for Research on Cancer 2010. [cited September 2010] Available from: http://globocan.iarc.fr
2. Parkin DM, Whelan S, Ferlay J, Storm H. Cancer Incidence in Five Continents, Vol. I to VIII. Lyon: IARC scientific publication; 2002;vol. 1 to VIII:78.
3. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189(1):12-19.
4. de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. The Lancet infectious diseases 2007;7(7):453-459.
5. Anttila A, Ronco G, Clifford G, Bray F, Hakama M, Arbyn M, et al. Cervical cancer screening programmes and policies in 18 European countries. Br J Cancer 2004;91(5):935-941.
6. Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low-and middle-income developing countries. Bull World Health Organ 2001;79(10):954-962.
7. Spadea T, D'Errico A, Demaria M, Faggiano F, Pasian S, Zanetti R, et al. Educational inequalities in cancer incidence in Turin, Italy. Eur J Cancer Prev 2009;18(3):169-178.
8. Benard VB, Johnson CJ, Thompson TD, Roland KB, Lai SM, Cokkinides V, et al. Examining the association between socioeconomic status and potential human papillomavirus-associated cancers. Cancer 2008;113(10 Suppl):2910-2918.
9. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002 Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No 5, 2004, version 2.0.
10. WHO. Core Health Indicators. [Accessed 20/01/2007]; Available from: http://www3.who.int/whosis/core/core_select.cfm
11. PAHO. Regional Core Health Data Initiative. Table Generator System. [Accessed 20/01/2007]; Available from: http://www.paho.org/English/SHA/coredata/tabulator/newTabulator.htm
12. Organizacion Panamericana de Salud, Unidad de Análisis y Estadísticas de Salud (HA). Situación de Salud en las Américas: Indicadores Básicos 2006. Washington, D.C.: Organización Panamericana de la Salud; 2006.
13. Organización Panamericana de la Salud. Género, salud y desarrollo en las Americas: Indicadores Basicos 2005. Washington, D.C.: OPS, 2005.
14. United Nations Statistical Division. Statistical Databases. [Accessed 25/01/2007]; Available from: http://unstats.un.org/unsd/databases.htm
15. United Nations Development Programme. Human Development Report, 2006. New York City: UNDP, 2006.
16. WHO/ICO. Information Centre on HPV and Cervical Cancer (HPV Information Centre). [Accessed 2011 15 of July]; Available from: www. who.int/hpvcentre
17. Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S. Cervical human papillomavirus prevalence in 5 continents: metaanalysis of 1 million women with normal cytological findings. J Infect Dis;202(12):1789-1799.
18. Murillo R, Almonte M, Pereira A, Ferrer E, Gamboa OA, Jeronimo J, et al. Cervical cancer screening programs in Latin America and the Caribbean. Vaccine 2008;26 Suppl 11:L37-48.
19. Ministerio de Salud Chile. Orientaciones para pesquisa y control del cáncer cervicouterino. Santiago: Minsal, 1998.
20. Martins L, Thuler L, Valente J. Coverage of the Pap smear in Brazil and its determining factors: a systematic literature review. [In Portuguese]. Rev Bras Ginecol Obstet 2005;27(8):485-492.
21. d'Ottaviano-Morelli MG, Zeferino L, Cecatti JG, Terrabuio DR, Martinez EZ. Prevalence of cervical intraepithelial neoplasia and invasive carcinoma based on cytological screening in the region of Campinas, Sao Paulo, Brazil. Cad Saude Publica 2004;20(1):153-159.
22. Zeferino LC, Pinotti JA, Jorge JP, Westin MC, Tambascia JK, Montemor EB. Organization of cervical cancer screening in Campinas and surrounding region, Sao Paulo State, Brazil. Cad Saude Publica 2006;22(9):1909-1914.
23. MIDEPLAN. Encuesta CASEN. Santiago de Chile 2006.
24. Ministerio de Salud de la Nación. Encuesta Nacional de Factores de Riesgo 2005: Argentina. Instituto Nacional de Estadísticas y Censos de Argentina; 2006.
25. Chen M, Rosero L, Brenes G, León M, Gonzalez M, Vanegas J. Salud reproductiva y migración nicaragüense en Costa Rica 1999-2000: Resultados de una Encuesta Nacional de Salud Reproductiva. San José: Programa Centroamericano de Población (PCP) de la Escuela de Estadística e Instituto de Investigaciones en Salud (INISA), Universidad de Costa Rica; 2001.
26. Fernandez-Garrote L, Lence-Anta JJ, Cabezas-Cruz E, Romero T, Camacho R. Evaluation of the cervical cancer control program in Cuba. Bull Pan Am Health Organ 1996;30(4):387-391.
27. Ojeda G, Ordóñez GM, Ochoa LH. Asociación Pro-Bienestar de la Familia Colombiana. Salud sexual y reproductiva: resultados encuesta nacional de demografía y salud, 2005. Bogota, Colombia: Asociación Probienestar de la Familia Colombiana, PROFAMILIA, 2005.
28. Centro de Estudios de Población y Paternidad Responsable (Ecuador), Centers for Disease Control (U.S.). Ecuador, ENDEMAIN-2004: informe preliminar. Quito, Ecuador [Atlanta, Georgia]: CEPAR; Centros para el Control de Enfermedades, 2005.
29. Centro Paraguayo de Estudios de Población. Centers for Disease Control and Prevention (U.S.), United States. Agency for International Development. Encuesta nacional de demografía y salud sexual y reproductiva 2004, ENDSSR 2004: informe resumido. Asunción, Paraguay: CEPEP, CDC, USAID, 2004.
30. Subsecretaria de Prevención y Protección de la Salud. Programa de Acciín: Cáncer Cervicouterino. Mexico: Secretaría de Salud, 2002.
31. MIDEPLAN. Encuesta CASEN. Santiago de Chile 2003.
32. o 480/98, Buenos Aires: Buenos Aires, 1998.
33. Monteith R, Stupp PW, McCracken SD, National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Reproductive Health. Reproductive, maternal and child health in Central America: trends and challenges facing women and children: El Salvador, Guatemala, Hondouras, Nicaragua. Atlanta, GA: USAID, 2005.
34. Aguirre R, Bonino M, Espino A, Sapriza G. Programa Mujer y Género del Ministerio de Salud Pública. Diagnóstico de situación sobre género y salud en Uruguay. Washington: Panamerican Health Organization, 2006.
35. Lewis J. Analisis de la situacion del cancer cervicouterino en America Latina y el Caribe. Washington, D.C.: OPS, 2004.
36. Ministerio de Salud Pública de Guatemala. Encuesta Nacional de Salud Materno Infantil 2002 (Mujeres). Guatemala: Ministerio de Salud, 2002.
37. Instituto Nacional de Estadística e Informática (INEI) de Perú. Encuesta nacional de hogares. Perú: INEI, 1998.
38. Instituto Nacional de Estadísticas y Censos de Nicaragua. Encuesta Nicaragüense de Demografía y Salud. Nicaragua: INEI, 2001.
39. Hernández-Ávila M, Lazcano-Ponce E, Martínerz-Montañez O. Public Policies For HPV Screening and Vaccination in Mexico. 27th International Papillomavirus Conference and Clinical Workshop. Berlin, Germany September 17-22, 2011.
40. Instituto Nacional Cancer. Programa Nacional de Controle do Cancer do Colo do Utero: Prevencao. Brasil: INCA Ministerio da Saude;. 2011. [Accessed 10/11/2011]; Available from: http://www1.inca.gov.br/conteudo_view.asp?id=327
41. Ministerio de Salud de Perú. Mas de 85 mil niñas de 10 años serán vacuandas contral el VPH en Lima y Callao. [Internet]. Perú;. 7 de Febrero 2011. [Accessed 01/12/2011]; Available from: http://www.minsa.gob.pe/portada/prensa/notas_auxiliar.asp?nota=9915
42. Ministerio de Salud, Presidencia de la Nación. Introducción de nuevas vacunas: vacuna contra el Virus Papiloma Humano (VPH)[Internet]. Buenos Aires: Republica Argentina; 15 de Agosto 2011. [Accessed 10/11/2012]; Available from: http://www.msal.gov.ar/index.php/component/content/article/46/185-vph
43. Ostrander M. Panama first in region to provide free HPV vaccine to young adolescent girls [Internet] Panama: Unicef; 28 October [cited 20/11/2011]; Available from: http://www.unicef.org/infobycountry/panama_46169.html
44. Drain PK, Holmes KK, Hughes JP, Koutsky LA. Determinants of cervical cancer rates in developing countries. Int J Cancer 2002;100(2):199-205.
45. Eluf-Neto J, Nascimento CM. Cervical cancer in Latin America. Semin Oncol 2001;28(2):188-97.
46. Schaap MM, Kunst AE. Monitoring of socio-economic inequalities in smoking: learning from the experiences of recent scientific studies. Public Health 2009;123(2):103-109.
47. dos Santos Silva I, Beral V. Socioeconomic differences in reproductive behaviour. IARC Scientific Publications 1997(138):285-308.
48. Currin LG, Jack RH, Linklater KM, Mak V, Moller H, Davies EA. Inequalities in the incidence of cervical cancer in South East England 2001-2005: an investigation of population risk factors. BMC Public Health 2009;9:62.
49. Sankaranarayanan R. Royal Society of Tropical Medicine and Hygiene meeting at Manson House, London 17 January 2002. Cervical cancer in developing countries. Trans R Soc Trop Med Hyg 2002;96(6):580-585.
50. Parikh S, Brennan P, Boffetta P. Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer 2003;105(5):687-691.
51. Bermudez A. Can we do the same in the developing world? Gynecol Oncol 2005;99(3 Suppl 1):S192-S196.
52. Hunter JL. Cervical cancer in Iquitos, Peru: local realities to guide prevention planning. Cad Saude Publica 2004;20(1):160-171.
53. Denny L, Quinn M, Sankaranarayanan R. Chapter 8: Screening for cervical cancer in developing countries. Vaccine 2006;24 Suppl 3:S71-S77.
54. Mauad EC, Nicolau SM, Moreira LF, Haikel RL, Jr., Longatto-Filho A, Baracat EC. Adherence to cervical and breast cancer programs is crucial to improving screening performance. Rural Remote Health 2009;9(3):1241.